ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Subcutaneous Biologics Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-30W5653
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Subcutaneous Biologics Market Insights Forecast to 2028
BUY CHAPTERS

Global Subcutaneous Biologics Market Research Report 2025

Code: QYRE-Auto-30W5653
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Pfizer Inc
Genentech Inc
Novartis
Biogen Idec
AbbVie
F. Hoffmann-La Roche AG
Bristol–Myers Squibb
Eisai Co Ltd
Takeda Pharmaceuticals Ltd.
Alnylam Pharmaceuticals
Bayer
GlaxoSmithKline PLC

Subcutaneous Biologics Market

The global market for Subcutaneous Biologics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances.
North American market for Subcutaneous Biologics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Subcutaneous Biologics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Subcutaneous Biologics in Hospital pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Subcutaneous Biologics include Abbott Laboratories, Pfizer Inc., Genentech Inc., Novartis AG, Biogen Idec, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb, Eisai Inc., Takeda Pharmaceuticals Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Biologics.
The Subcutaneous Biologics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Subcutaneous Biologics Market Report

Report Metric Details
Report Name Subcutaneous Biologics Market
Segment by Type
  • Syringe
  • Wearable injector
  • Automatic injector
  • Implants
Segment by Application
  • Hospital pharmacies
  • Retail pharmacies
  • Drug stores
  • Online pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Pfizer Inc., Genentech Inc., Novartis AG, Biogen Idec, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb, Eisai Inc., Takeda Pharmaceuticals Ltd., Alnylam Pharmaceuticals, Bayer AG, GlaxoSmithKline
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Subcutaneous Biologics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Subcutaneous Biologics Market report?

Ans: The main players in the Subcutaneous Biologics Market are Abbott Laboratories, Pfizer Inc., Genentech Inc., Novartis AG, Biogen Idec, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb, Eisai Inc., Takeda Pharmaceuticals Ltd., Alnylam Pharmaceuticals, Bayer AG, GlaxoSmithKline

What are the Application segmentation covered in the Subcutaneous Biologics Market report?

Ans: The Applications covered in the Subcutaneous Biologics Market report are Hospital pharmacies, Retail pharmacies, Drug stores, Online pharmacies

What are the Type segmentation covered in the Subcutaneous Biologics Market report?

Ans: The Types covered in the Subcutaneous Biologics Market report are Syringe, Wearable injector, Automatic injector, Implants

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Subcutaneous Biologics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Syringe
1.2.3 Wearable injector
1.2.4 Automatic injector
1.2.5 Implants
1.3 Market by Application
1.3.1 Global Subcutaneous Biologics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital pharmacies
1.3.3 Retail pharmacies
1.3.4 Drug stores
1.3.5 Online pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Subcutaneous Biologics Market Perspective (2020-2031)
2.2 Global Subcutaneous Biologics Growth Trends by Region
2.2.1 Global Subcutaneous Biologics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Subcutaneous Biologics Historic Market Size by Region (2020-2025)
2.2.3 Subcutaneous Biologics Forecasted Market Size by Region (2026-2031)
2.3 Subcutaneous Biologics Market Dynamics
2.3.1 Subcutaneous Biologics Industry Trends
2.3.2 Subcutaneous Biologics Market Drivers
2.3.3 Subcutaneous Biologics Market Challenges
2.3.4 Subcutaneous Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Subcutaneous Biologics Players by Revenue
3.1.1 Global Top Subcutaneous Biologics Players by Revenue (2020-2025)
3.1.2 Global Subcutaneous Biologics Revenue Market Share by Players (2020-2025)
3.2 Global Subcutaneous Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Subcutaneous Biologics Revenue
3.4 Global Subcutaneous Biologics Market Concentration Ratio
3.4.1 Global Subcutaneous Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Biologics Revenue in 2024
3.5 Global Key Players of Subcutaneous Biologics Head office and Area Served
3.6 Global Key Players of Subcutaneous Biologics, Product and Application
3.7 Global Key Players of Subcutaneous Biologics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Subcutaneous Biologics Breakdown Data by Type
4.1 Global Subcutaneous Biologics Historic Market Size by Type (2020-2025)
4.2 Global Subcutaneous Biologics Forecasted Market Size by Type (2026-2031)
5 Subcutaneous Biologics Breakdown Data by Application
5.1 Global Subcutaneous Biologics Historic Market Size by Application (2020-2025)
5.2 Global Subcutaneous Biologics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Subcutaneous Biologics Market Size (2020-2031)
6.2 North America Subcutaneous Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Subcutaneous Biologics Market Size by Country (2020-2025)
6.4 North America Subcutaneous Biologics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Subcutaneous Biologics Market Size (2020-2031)
7.2 Europe Subcutaneous Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Subcutaneous Biologics Market Size by Country (2020-2025)
7.4 Europe Subcutaneous Biologics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Subcutaneous Biologics Market Size (2020-2031)
8.2 Asia-Pacific Subcutaneous Biologics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Subcutaneous Biologics Market Size by Region (2020-2025)
8.4 Asia-Pacific Subcutaneous Biologics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Subcutaneous Biologics Market Size (2020-2031)
9.2 Latin America Subcutaneous Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Subcutaneous Biologics Market Size by Country (2020-2025)
9.4 Latin America Subcutaneous Biologics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Subcutaneous Biologics Market Size (2020-2031)
10.2 Middle East & Africa Subcutaneous Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Subcutaneous Biologics Market Size by Country (2020-2025)
10.4 Middle East & Africa Subcutaneous Biologics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Subcutaneous Biologics Introduction
11.1.4 Abbott Laboratories Revenue in Subcutaneous Biologics Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Subcutaneous Biologics Introduction
11.2.4 Pfizer Inc. Revenue in Subcutaneous Biologics Business (2020-2025)
11.2.5 Pfizer Inc. Recent Development
11.3 Genentech Inc.
11.3.1 Genentech Inc. Company Details
11.3.2 Genentech Inc. Business Overview
11.3.3 Genentech Inc. Subcutaneous Biologics Introduction
11.3.4 Genentech Inc. Revenue in Subcutaneous Biologics Business (2020-2025)
11.3.5 Genentech Inc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Subcutaneous Biologics Introduction
11.4.4 Novartis AG Revenue in Subcutaneous Biologics Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 Biogen Idec
11.5.1 Biogen Idec Company Details
11.5.2 Biogen Idec Business Overview
11.5.3 Biogen Idec Subcutaneous Biologics Introduction
11.5.4 Biogen Idec Revenue in Subcutaneous Biologics Business (2020-2025)
11.5.5 Biogen Idec Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Subcutaneous Biologics Introduction
11.6.4 AbbVie Inc. Revenue in Subcutaneous Biologics Business (2020-2025)
11.6.5 AbbVie Inc. Recent Development
11.7 F. Hoffmann-La Roche AG
11.7.1 F. Hoffmann-La Roche AG Company Details
11.7.2 F. Hoffmann-La Roche AG Business Overview
11.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Introduction
11.7.4 F. Hoffmann-La Roche AG Revenue in Subcutaneous Biologics Business (2020-2025)
11.7.5 F. Hoffmann-La Roche AG Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Subcutaneous Biologics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Subcutaneous Biologics Business (2020-2025)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Eisai Inc.
11.9.1 Eisai Inc. Company Details
11.9.2 Eisai Inc. Business Overview
11.9.3 Eisai Inc. Subcutaneous Biologics Introduction
11.9.4 Eisai Inc. Revenue in Subcutaneous Biologics Business (2020-2025)
11.9.5 Eisai Inc. Recent Development
11.10 Takeda Pharmaceuticals Ltd.
11.10.1 Takeda Pharmaceuticals Ltd. Company Details
11.10.2 Takeda Pharmaceuticals Ltd. Business Overview
11.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Introduction
11.10.4 Takeda Pharmaceuticals Ltd. Revenue in Subcutaneous Biologics Business (2020-2025)
11.10.5 Takeda Pharmaceuticals Ltd. Recent Development
11.11 Alnylam Pharmaceuticals
11.11.1 Alnylam Pharmaceuticals Company Details
11.11.2 Alnylam Pharmaceuticals Business Overview
11.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Introduction
11.11.4 Alnylam Pharmaceuticals Revenue in Subcutaneous Biologics Business (2020-2025)
11.11.5 Alnylam Pharmaceuticals Recent Development
11.12 Bayer AG
11.12.1 Bayer AG Company Details
11.12.2 Bayer AG Business Overview
11.12.3 Bayer AG Subcutaneous Biologics Introduction
11.12.4 Bayer AG Revenue in Subcutaneous Biologics Business (2020-2025)
11.12.5 Bayer AG Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Subcutaneous Biologics Introduction
11.13.4 GlaxoSmithKline Revenue in Subcutaneous Biologics Business (2020-2025)
11.13.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Pfizer Inc
Genentech Inc
Novartis
Biogen Idec
AbbVie
F. Hoffmann-La Roche AG
Bristol–Myers Squibb
Eisai Co Ltd
Takeda Pharmaceuticals Ltd.
Alnylam Pharmaceuticals
Bayer
GlaxoSmithKline PLC
List of Tables
 Table 1. Global Subcutaneous Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Syringe
 Table 3. Key Players of Wearable injector
 Table 4. Key Players of Automatic injector
 Table 5. Key Players of Implants
 Table 6. Global Subcutaneous Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Subcutaneous Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Subcutaneous Biologics Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Subcutaneous Biologics Market Share by Region (2020-2025)
 Table 10. Global Subcutaneous Biologics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Subcutaneous Biologics Market Share by Region (2026-2031)
 Table 12. Subcutaneous Biologics Market Trends
 Table 13. Subcutaneous Biologics Market Drivers
 Table 14. Subcutaneous Biologics Market Challenges
 Table 15. Subcutaneous Biologics Market Restraints
 Table 16. Global Subcutaneous Biologics Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Subcutaneous Biologics Market Share by Players (2020-2025)
 Table 18. Global Top Subcutaneous Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Biologics as of 2024)
 Table 19. Ranking of Global Top Subcutaneous Biologics Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Subcutaneous Biologics Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Subcutaneous Biologics, Headquarters and Area Served
 Table 22. Global Key Players of Subcutaneous Biologics, Product and Application
 Table 23. Global Key Players of Subcutaneous Biologics, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Subcutaneous Biologics Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Subcutaneous Biologics Revenue Market Share by Type (2020-2025)
 Table 27. Global Subcutaneous Biologics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Subcutaneous Biologics Revenue Market Share by Type (2026-2031)
 Table 29. Global Subcutaneous Biologics Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Subcutaneous Biologics Revenue Market Share by Application (2020-2025)
 Table 31. Global Subcutaneous Biologics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Subcutaneous Biologics Revenue Market Share by Application (2026-2031)
 Table 33. North America Subcutaneous Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Subcutaneous Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Subcutaneous Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Subcutaneous Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Subcutaneous Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Subcutaneous Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Subcutaneous Biologics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Subcutaneous Biologics Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Subcutaneous Biologics Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Subcutaneous Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Subcutaneous Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Subcutaneous Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Subcutaneous Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Subcutaneous Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Subcutaneous Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Abbott Laboratories Company Details
 Table 49. Abbott Laboratories Business Overview
 Table 50. Abbott Laboratories Subcutaneous Biologics Product
 Table 51. Abbott Laboratories Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 52. Abbott Laboratories Recent Development
 Table 53. Pfizer Inc. Company Details
 Table 54. Pfizer Inc. Business Overview
 Table 55. Pfizer Inc. Subcutaneous Biologics Product
 Table 56. Pfizer Inc. Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 57. Pfizer Inc. Recent Development
 Table 58. Genentech Inc. Company Details
 Table 59. Genentech Inc. Business Overview
 Table 60. Genentech Inc. Subcutaneous Biologics Product
 Table 61. Genentech Inc. Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 62. Genentech Inc. Recent Development
 Table 63. Novartis AG Company Details
 Table 64. Novartis AG Business Overview
 Table 65. Novartis AG Subcutaneous Biologics Product
 Table 66. Novartis AG Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 67. Novartis AG Recent Development
 Table 68. Biogen Idec Company Details
 Table 69. Biogen Idec Business Overview
 Table 70. Biogen Idec Subcutaneous Biologics Product
 Table 71. Biogen Idec Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 72. Biogen Idec Recent Development
 Table 73. AbbVie Inc. Company Details
 Table 74. AbbVie Inc. Business Overview
 Table 75. AbbVie Inc. Subcutaneous Biologics Product
 Table 76. AbbVie Inc. Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 77. AbbVie Inc. Recent Development
 Table 78. F. Hoffmann-La Roche AG Company Details
 Table 79. F. Hoffmann-La Roche AG Business Overview
 Table 80. F. Hoffmann-La Roche AG Subcutaneous Biologics Product
 Table 81. F. Hoffmann-La Roche AG Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 82. F. Hoffmann-La Roche AG Recent Development
 Table 83. Bristol-Myers Squibb Company Details
 Table 84. Bristol-Myers Squibb Business Overview
 Table 85. Bristol-Myers Squibb Subcutaneous Biologics Product
 Table 86. Bristol-Myers Squibb Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 87. Bristol-Myers Squibb Recent Development
 Table 88. Eisai Inc. Company Details
 Table 89. Eisai Inc. Business Overview
 Table 90. Eisai Inc. Subcutaneous Biologics Product
 Table 91. Eisai Inc. Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 92. Eisai Inc. Recent Development
 Table 93. Takeda Pharmaceuticals Ltd. Company Details
 Table 94. Takeda Pharmaceuticals Ltd. Business Overview
 Table 95. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product
 Table 96. Takeda Pharmaceuticals Ltd. Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 97. Takeda Pharmaceuticals Ltd. Recent Development
 Table 98. Alnylam Pharmaceuticals Company Details
 Table 99. Alnylam Pharmaceuticals Business Overview
 Table 100. Alnylam Pharmaceuticals Subcutaneous Biologics Product
 Table 101. Alnylam Pharmaceuticals Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 102. Alnylam Pharmaceuticals Recent Development
 Table 103. Bayer AG Company Details
 Table 104. Bayer AG Business Overview
 Table 105. Bayer AG Subcutaneous Biologics Product
 Table 106. Bayer AG Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 107. Bayer AG Recent Development
 Table 108. GlaxoSmithKline Company Details
 Table 109. GlaxoSmithKline Business Overview
 Table 110. GlaxoSmithKline Subcutaneous Biologics Product
 Table 111. GlaxoSmithKline Revenue in Subcutaneous Biologics Business (2020-2025) & (US$ Million)
 Table 112. GlaxoSmithKline Recent Development
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Subcutaneous Biologics Picture
 Figure 2. Global Subcutaneous Biologics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Subcutaneous Biologics Market Share by Type: 2024 VS 2031
 Figure 4. Syringe Features
 Figure 5. Wearable injector Features
 Figure 6. Automatic injector Features
 Figure 7. Implants Features
 Figure 8. Global Subcutaneous Biologics Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Subcutaneous Biologics Market Share by Application: 2024 VS 2031
 Figure 10. Hospital pharmacies Case Studies
 Figure 11. Retail pharmacies Case Studies
 Figure 12. Drug stores Case Studies
 Figure 13. Online pharmacies Case Studies
 Figure 14. Subcutaneous Biologics Report Years Considered
 Figure 15. Global Subcutaneous Biologics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Subcutaneous Biologics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Subcutaneous Biologics Market Share by Region: 2024 VS 2031
 Figure 18. Global Subcutaneous Biologics Market Share by Players in 2024
 Figure 19. Global Top Subcutaneous Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Biologics as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Subcutaneous Biologics Revenue in 2024
 Figure 21. North America Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Subcutaneous Biologics Market Share by Country (2020-2031)
 Figure 23. United States Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Subcutaneous Biologics Market Share by Country (2020-2031)
 Figure 27. Germany Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Subcutaneous Biologics Market Share by Region (2020-2031)
 Figure 35. China Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Subcutaneous Biologics Market Share by Country (2020-2031)
 Figure 43. Mexico Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Subcutaneous Biologics Market Share by Country (2020-2031)
 Figure 47. Turkey Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Subcutaneous Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Abbott Laboratories Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 51. Pfizer Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 52. Genentech Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 53. Novartis AG Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 54. Biogen Idec Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 55. AbbVie Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 56. F. Hoffmann-La Roche AG Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 58. Eisai Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 59. Takeda Pharmaceuticals Ltd. Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 60. Alnylam Pharmaceuticals Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 61. Bayer AG Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 62. GlaxoSmithKline Revenue Growth Rate in Subcutaneous Biologics Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Biologic Medical Product Market Research Report 2025
Global Innovations in Biologics and Biosimilars Market Research Report 2024
Global Biologics and Biosimilars Market Research Report 2025
Global Biologics Drug Development Market Research Report 2024
Innovative Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Innovative Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biosimilars and Innovative Biological Drugs Market Research Report 2024
Global Cancer Biologics Market Research Report 2024
Global Biotechnological Drugs Market Research Report 2025
Global Biologic Device Combination Products Market Research Report 2025
Global Biologics Outsourcing Services Market Research Report 2024
Global Biologic Medications for Psoriasis Market Research Report 2024
Global Generic vs Innovator Drugs Market Research Report 2024
Global Cancer Biopharmaceuticals Market Insights Forecast to 2030
Global Subcutaneous Medicine Delivery Devices Market Research Report 2024
Global GMP Biologics Market Insights Forecast to 2030
Chemical Drug and Biologic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biologics Analytical Services Market Research Report 2024
Veterinary Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions